183 related articles for article (PubMed ID: 34207568)
1. Altered Expression of
Englert-Golon M; Andrusiewicz M; Żbikowska A; Chmielewska M; Sajdak S; Kotwicka M
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34207568
[TBL] [Abstract][Full Text] [Related]
2. Expression of estrogen receptors, PELP1, and SRC in human spermatozoa and their associations with semen quality.
Skibińska I; Andrusiewicz M; Jendraszak M; Żbikowska A; Jędrzejczak P; Kotwicka M
Hum Cell; 2023 Mar; 36(2):554-567. PubMed ID: 36577884
[TBL] [Abstract][Full Text] [Related]
3. Expression of Estrogen Receptor Coactivator Proline-, Glutamic Acid- and Leucine-Rich Protein 1 within Paraspinal Muscles in Adolescents with Idiopathic Scoliosis.
Skibinska I; Tomaszewski M; Andrusiewicz M; Urbaniak P; Czarnecka-Klos R; Shadi M; Kotwicki T; Kotwicka M
PLoS One; 2016; 11(4):e0152286. PubMed ID: 27045366
[TBL] [Abstract][Full Text] [Related]
4. Expression of oestrogen receptors (GPER, ESR1, ESR2) in human ductuli efferentes and proximal epididymis.
Rago V; Romeo F; Giordano F; Malivindi R; Pezzi V; Casaburi I; Carpino A
Andrology; 2018 Jan; 6(1):192-198. PubMed ID: 29145706
[TBL] [Abstract][Full Text] [Related]
5. Role of PELP1/MNAR signaling in ovarian tumorigenesis.
Dimple C; Nair SS; Rajhans R; Pitcheswara PR; Liu J; Balasenthil S; Le XF; Burow ME; Auersperg N; Tekmal RR; Broaddus RR; Vadlamudi RK
Cancer Res; 2008 Jun; 68(12):4902-9. PubMed ID: 18559538
[TBL] [Abstract][Full Text] [Related]
6. PELP1 and SRC kinase as important molecules in the estrogen-mediated pathway in human testis and epididymis.
Skibińska I; Andrusiewicz M; Jendraszak M; Żbikowska A; Żaba C; Kotwicka M
Acta Biochim Pol; 2023 May; 70(2):447-456. PubMed ID: 37159918
[TBL] [Abstract][Full Text] [Related]
7. The prognostic value of estrogen receptor beta and proline-, glutamic acid- and leucine-rich protein 1 (PELP1) expression in ovarian cancer.
Aust S; Horak P; Pils D; Pils S; Grimm C; Horvat R; Tong D; Schmid B; Speiser P; Reinthaller A; Polterauer S
BMC Cancer; 2013 Mar; 13():115. PubMed ID: 23497172
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of proline-, glutamic acid- and leucine-rich protein PELP1 in non-small cell lung cancer.
Słowikowski BK; Gałęcki B; Dyszkiewicz W; Jagodziński PP
Biomed Pharmacother; 2015 Jul; 73():97-101. PubMed ID: 26211588
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of proline, glutamic acid, leucine rich protein 1 (PELP1) in triple-negative breast cancer: a retrospective study on 129 cases.
Zhang Y; Dai J; McNamara KM; Bai B; Shi M; Chan MS; Liu M; Sasano H; Wang X; Li X; Liu L; Ma Y; Cao S; Xing Y; Zhao B; Song Y; Wang L
BMC Cancer; 2015 Oct; 15():699. PubMed ID: 26472563
[TBL] [Abstract][Full Text] [Related]
10. Modulation of in situ estrogen synthesis by proline-, glutamic acid-, and leucine-rich protein-1: potential estrogen receptor autocrine signaling loop in breast cancer cells.
Rajhans R; Nair HB; Nair SS; Cortez V; Ikuko K; Kirma NB; Zhou D; Holden AE; Brann DW; Chen S; Tekmal RR; Vadlamudi RK
Mol Endocrinol; 2008 Mar; 22(3):649-64. PubMed ID: 18079323
[TBL] [Abstract][Full Text] [Related]
11. Regulation of aromatase induction by nuclear receptor coregulator PELP1.
Vadlamudi RK; Rajhans R; Chakravarty D; Nair BC; Nair SS; Evans DB; Chen S; Tekmal RR
J Steroid Biochem Mol Biol; 2010 Feb; 118(4-5):211-8. PubMed ID: 19800002
[TBL] [Abstract][Full Text] [Related]
12. PELP1 is a novel oncogene in gastric tumorigenesis and negatively regulated by miR-15 family microRNAs.
Ma C; Miao C; Wang C; Song F; Luo M
Cancer Biomark; 2019; 26(1):1-9. PubMed ID: 31322541
[TBL] [Abstract][Full Text] [Related]
13. PELP1 overexpression in the mouse mammary gland results in the development of hyperplasia and carcinoma.
Cortez V; Samayoa C; Zamora A; Martinez L; Tekmal RR; Vadlamudi RK
Cancer Res; 2014 Dec; 74(24):7395-405. PubMed ID: 25377474
[TBL] [Abstract][Full Text] [Related]
14. The pattern of proline, glutamic acid, and leucine-rich protein 1 expression in Chinese women with primary breast cancer.
Zhang Y; Wang P; Shi M; Sasano H; Chan MS; Dai J; Guo L; Liu M; Wang X; Ma Y; Wang L
Int J Biol Markers; 2014 Mar; 29(1):e1-7. PubMed ID: 24627205
[TBL] [Abstract][Full Text] [Related]
15. PELP1 oncogenic functions involve alternative splicing via PRMT6.
Mann M; Zou Y; Chen Y; Brann D; Vadlamudi R
Mol Oncol; 2014 Mar; 8(2):389-400. PubMed ID: 24447537
[TBL] [Abstract][Full Text] [Related]
16. Estrogens Correlate with PELP1 Expression in ER Positive Breast Cancer.
Flågeng MH; Knappskog S; Gjerde J; Lønning PE; Mellgren G
PLoS One; 2015; 10(8):e0134351. PubMed ID: 26247365
[TBL] [Abstract][Full Text] [Related]
17. Oncogenic potential of the nuclear receptor coregulator proline-, glutamic acid-, leucine-rich protein 1/modulator of the nongenomic actions of the estrogen receptor.
Rajhans R; Nair S; Holden AH; Kumar R; Tekmal RR; Vadlamudi RK
Cancer Res; 2007 Jun; 67(11):5505-12. PubMed ID: 17545633
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic targeting of PELP1 prevents ovarian cancer growth and metastasis.
Chakravarty D; Roy SS; Babu CR; Dandamudi R; Curiel TJ; Vivas-Mejia P; Lopez-Berestein G; Sood AK; Vadlamudi RK
Clin Cancer Res; 2011 Apr; 17(8):2250-9. PubMed ID: 21421858
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of mTOR signaling reduces PELP1-mediated tumor growth and therapy resistance.
Gonugunta VK; Sareddy GR; Krishnan SR; Cortez V; Roy SS; Tekmal RR; Vadlamudi RK
Mol Cancer Ther; 2014 Jun; 13(6):1578-88. PubMed ID: 24688046
[TBL] [Abstract][Full Text] [Related]
20. Proline-, glutamic acid-, and leucine-rich protein-1 is essential in growth factor regulation of signal transducers and activators of transcription 3 activation.
Manavathi B; Nair SS; Wang RA; Kumar R; Vadlamudi RK
Cancer Res; 2005 Jul; 65(13):5571-7. PubMed ID: 15994929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]